{"id":"https://openalex.org/W2891237382","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","title":"Outcomes and prognostic factors for acral lentiginous melanoma in Peruvian patients.","display_name":"Outcomes and prognostic factors for acral lentiginous melanoma in Peruvian patients.","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2891237382","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","mag":"2891237382"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.e21061","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2891237382"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091899736","display_name":"Cindy Elizabeth Alcarraz","orcid":"https://orcid.org/0000-0001-8488-8171","observed_orcids":["https://orcid.org/0000-0001-8488-8171"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Cindy Elizabeth Alcarraz","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082959086","display_name":"Zaida Morante","orcid":"https://orcid.org/0000-0003-2952-6068","observed_orcids":["https://orcid.org/0000-0003-2952-6068"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Zaida Morante","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neopl\u00e1scias, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neopl\u00e1scias, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017769557","display_name":"Luis A. Mas","orcid":"https://orcid.org/0000-0002-2323-9271","observed_orcids":["https://orcid.org/0000-0002-2323-9271"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Luis Mas","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024747592","display_name":"Silvia P. Neciosup","orcid":"https://orcid.org/0000-0002-2657-9853","observed_orcids":["https://orcid.org/0000-0002-2657-9853"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Silvia P. Neciosup","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gabriela Calderon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Gabriela Calderon","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007374371","display_name":"Jorge Antonio Dunstan","orcid":"https://orcid.org/0000-0002-4148-6858","observed_orcids":["https://orcid.org/0000-0002-4148-6858"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Jorge Antonio Dunstan","raw_affiliation_strings":["Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035403028","display_name":"Julio E. Abugattas Saba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Julio E. Abugattas Saba","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Surquillo, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Surquillo, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049679970","display_name":"Henry G\u00f3mez","orcid":"https://orcid.org/0000-0002-3415-9701","observed_orcids":["https://orcid.org/0000-0002-3415-9701","https://orcid.org/0000-0003-2660-1843"]},"institutions":[{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["PE"],"is_corresponding":false,"raw_author_name":"Henry Leonidas Gomez","raw_affiliation_strings":["ECOG/ACRIN, and The Instituto Nacional de Enfermedades Neoplasicas INEN, Lima, Peru;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ECOG/ACRIN, and The Instituto Nacional de Enfermedades Neoplasicas INEN, Lima, Peru;","institution_ids":["https://openalex.org/I4210123325"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210123325"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"e21061","last_page":"e21061"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acral-lentiginous-melanoma","display_name":"acral lentiginous melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lymph-node-involvement","display_name":"lymph node involvement","score":0.8109999895095825},{"id":"https://openalex.org/keywords/clinical-stage","display_name":"clinical stage","score":0.7620000243186951},{"id":"https://openalex.org/keywords/breslow-thickness","display_name":"Breslow thickness","score":0.9190000295639038},{"id":"https://openalex.org/keywords/ulceration","display_name":"ulceration","score":0.8970000147819519},{"id":"https://openalex.org/keywords/perineural-invasion","display_name":"perineural invasion","score":0.8669999837875366},{"id":"https://openalex.org/keywords/vascular-invasion","display_name":"vascular invasion","score":0.9229999780654907},{"id":"https://openalex.org/keywords/peruvian-patients","display_name":"Peruvian patients","score":0.6919999718666077},{"id":"https://openalex.org/keywords/lima","display_name":"Lima","score":0.9100000262260437},{"id":"https://openalex.org/keywords/foot-melanoma","display_name":"foot melanoma","score":0.828000009059906},{"id":"https://openalex.org/keywords/clinical-characteristics","display_name":"clinical features","score":0.4729999899864197},{"id":"https://openalex.org/keywords/pathological-features","display_name":"pathological features","score":0.47099998593330383},{"id":"https://openalex.org/keywords/age-and-sex-distribution","display_name":"age and sex distribution","score":0.652999997138977},{"id":"https://openalex.org/keywords/incidence-rates","display_name":"incidence rates","score":0.34700000286102295},{"id":"https://openalex.org/keywords/survivorship-curves","display_name":"survival curves","score":0.3140000104904175},{"id":"https://openalex.org/keywords/cox-proportional-hazards-model","display_name":"Cox proportional hazards model","score":0.6660000085830688},{"id":"https://openalex.org/keywords/kaplan-meier","display_name":"Kaplan-Meier","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9491462707519531},{"id":"https://openalex.org/C2780589465","wikidata":"https://www.wikidata.org/wiki/Q4675038","display_name":"Acral lentiginous melanoma","level":3,"score":0.9092148542404175},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5782965421676636},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.550475001335144},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.541724443435669},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5196232199668884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5052714943885803},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5023941993713379},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.46567389369010925},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4573572874069214},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.411430686712265},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3585958480834961},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.23729723691940308},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.e21061","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21061","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046649373","https://openalex.org/W2741652292","https://openalex.org/W2736167445","https://openalex.org/W3011977455","https://openalex.org/W2806031715","https://openalex.org/W4387037372","https://openalex.org/W2143173538","https://openalex.org/W2166050321","https://openalex.org/W2621161007","https://openalex.org/W3012909157"],"abstract_inverted_index":{"e21061":[0],"Background:":[1],"Acral":[2],"lentiginous":[3,284],"melanoma":[4,13,33,84,285],"(ALM)":[5],"is":[6],"the":[7,56,67,92,106,114,126,147,166,176,185,235,289,296],"most":[8,180,290],"common":[9],"subtype":[10],"of":[11,32,50,71,79,146,169,175,241],"malignant":[12,83],"in":[14,34,64,144,165,260],"acral":[15,283],"locations.":[16],"It":[17],"has":[18],"a":[19,77],"more":[20,163],"aggressive":[21],"behavior":[22],"and":[23,58,61,109,160,201,210,250,268],"poorer":[24],"prognosis.":[25],"The":[26,48,150,179,208,216,256],"age":[27,152,167,209],"\u2013":[28],"specific":[29],"incidence":[30],"rate":[31],"Lima":[35],"-":[36,40,158],"Peru":[37],"between":[38,69],"2004":[39],"2005":[41],"was":[42,53,123,136,142,153,162,183,206,270,295],"2.04":[43],"cases":[44],"per":[45],"100,000":[46],"population.":[47,178],"aim":[49],"this":[51],"study":[52,177],"to":[54,66,88],"describe":[55],"clinical":[57,192,224,264],"pathological":[59],"features":[60],"overall":[62,120,221],"survival,":[63],"addition":[65],"differences":[68],"subgroups":[70],"patients.":[72],"Methods:":[73],"We":[74],"retrospectively":[75],"reviewed":[76],"database":[78],"patients":[80,190,262,281],"diagnosed":[81],"with":[82,125,263,282],"since":[85],"january":[86],"2009":[87],"december":[89],"2011":[90],"at":[91],"Instituto":[93],"Nacional":[94],"de":[95],"Enfermedades":[96],"Neoplasicas":[97],"(INEN).":[98],"Overall":[99],"survival":[100,121,222],"(OS)":[101,122],"curves":[102],"were":[103,111,191,212,223],"estimated":[104],"using":[105,113],"Kaplan-Meier":[107],"method":[108],"comparisons":[110],"done":[112],"log-rank":[115],"test.":[116],"Multivariate":[117],"analysis":[118],"for":[119,220],"perfomed":[124],"cox":[127],"proportional":[128],"hazard":[129],"regression":[130],"model.":[131],"A":[132],"p-value":[133],"<":[134,227,233,238,244,248,254,276],"0.05":[135],"considered":[137],"statistically":[138],"significant.":[139],"Results:":[140],"ALM":[141],"observed":[143],"62.2%":[145],"all-histologic":[148],"types.":[149],"median":[151],"62.48":[154],"years":[155],"(range:":[156],"26":[157],"96)":[159],"it":[161],"frequent":[164],"group":[168],"60-69":[170],"years.":[171],"Men":[172],"represented":[173],"55.1%":[174],"affected":[181],"location":[182],"on":[184],"foot":[186],"(24.3%).":[187],"Fourteen":[188],"(13.1%)":[189],"stage":[193,225,265],"I,":[194,266],"47":[195],"(43.9%)":[196],"II,":[197],"27":[198],"(25.2%)":[199],"III":[200,269],"8":[202],"(7.5%)":[203],"IV.":[204],"3yrs-OS":[205],"55.3%.":[207],"sex":[211],"not":[213],"prognostic":[214,293],"factors.":[215],"pathologic":[217],"factors":[218],"significant":[219],"(p":[226,232,237,243,247,253,275],"0.05),":[228,234],"lymph":[229,271],"node":[230,272],"involvement":[231,273,298],"Breslow":[236],"0.04),":[239],"presence":[240],"ulceration":[242],"0.012),":[245],"vascular":[246],"0.05)":[249],"perineural":[251],"invasion":[252],"0.008).":[255,277],"Independent":[257],"prognosis":[258],"factor":[259,294],"only":[261],"II":[267],"(N3)":[274],"Conclusions:":[278],"In":[279],"our":[280],"without":[286],"metastatic":[287],"disease,":[288],"important":[291],"independent":[292],"nodal":[297],"(N3).":[299]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2891237382","counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-09-27T00:00:00"}
